Novo Nordisk’s chief executive has signalled openness to listing the Danish drugmaker’s shares directly on the New York Stock Exchange. CEO Doustdar told a newspaper that he sees clear advantages in pursuing
On July 7, 2026, the Federal Reserve Board requested public comment on a proposed rule targeting anti-money laundering and countering the financing of terrorism program requirements. The proposal would amend Regulation H
More
On June 16, the Commodity Futures Trading Commission issued a Request for Information seeking public comment on whether its existing regulations unnecessarily hinder fintech firms. The initiative asks whether current CFTC rules,
More
DRDGOLD (NYSE: DRD) appears to be holding its ground on valuation metrics even as gold prices face renewed selling pressure in global markets. The South Africa-based gold producer has attracted analyst attention
More
Bayer has agreed a €3 billion ($3.4 billion) equity deal with New York-based asset manager Apollo for a minority stake in its long-acting reversible contraceptives business. The German pharmaceutical giant will retain
More
Governor Josh Stein signed Senate Bill 401, the NC Farm Act of 2025-2026, into law as Session Law 2026-11 on June 22, 2026. The bill passed the House 110 to 2 and
More
The UK Financial Conduct Authority is consulting on significant proposed changes to its Decisions Procedure and Penalties Manual, known as DEPP, which governs how financial penalties are calculated and imposed. The consultation,
More
AstraZeneca (AZN) £20 Billion Wipeout Drags FTSE 100 Lower As Computacenter (CCC) And Playtech Surge
London’s blue-chip index closed down 16 points at 10,472 on Thursday, with geopolitical uncertainty and a pharmaceutical setback weighing heavily on sentiment. AstraZeneca suffered a dramatic sell-off after its Phase III CARDIO-TTRansform
More
US manufacturing companies are contending with rising tariff costs and significant supply chain shifts that are reshaping their operational and financial outlooks. The sector has faced mounting pressure as trade policy uncertainty
More
Pharmacy benefit manager reform is changing the commercial and operational environment for pharmaceutical manufacturers, even where it stops short of imposing direct obligations on them. Manufacturer programs do not operate in isolation,
More
Patience in legal practice is not a passive quality — it is one of the most deliberate and consequential skills an in-house lawyer can develop. Writing for Above the Law, Lisa Lang
More